Researchers envisage the final version as an injection that could be personalized to each patient to improve effectiveness.

People with rheumatoid arthritis face a 46% higher risk of venous thromboembolism, regardless of age or BMI, according to a ...

The US Food and Drug Administration has approved a pill-sized device for treating rheumatoid arthritis, marking the first ...

A new clinical test may be able to predict which biologic may be the most effective for each individual with rheumatoid arthritis and help take the guesswork out of treatment, a new study suggests.

Reducing cardiovascular risk with immunomodulators: a randomised active comparator trial among patients with rheumatoid arthritis. Annals of the Rheumatic Diseases, 2022; ard-2022-223302 DOI: 10. ...

"Rheumatoid arthritis is when your immune system mistakenly attacks your own body," Liebowitz said. "It causes those symptoms: stiffness, pain, swelling, and it affects specific joints.

About 18 million people worldwide have rheumatoid arthritis. There are various medications — including steroids — used to treat symptoms, all with potential side effects.

People with autoimmune conditions may also be more likely to develop rheumatoid arthritis as "the immune system can target the joints, causing inflammation and resulting in pain, swelling, warmth ...